Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy (HCM) is associated with adverse left ventricular (LV) remodeling causing dysfunction and malignant arrhythmias. Severely affected patients present with disease onset during childhood and sudden cardiac death risk (SCD) stratification is of the highest importance in this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kathrin Pollmann, Emanuel Kaltenecker, Julia Schleihauf, Peter Ewert, Agnes Görlach, Cordula M. Wolf
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/56fe6d338de242908ba8135881ab8790
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56fe6d338de242908ba8135881ab8790
record_format dspace
spelling oai:doaj.org-article:56fe6d338de242908ba8135881ab87902021-11-25T18:00:57ZCompound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy10.3390/jcm102252562077-0383https://doaj.org/article/56fe6d338de242908ba8135881ab87902021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5256https://doaj.org/toc/2077-0383Hypertrophic cardiomyopathy (HCM) is associated with adverse left ventricular (LV) remodeling causing dysfunction and malignant arrhythmias. Severely affected patients present with disease onset during childhood and sudden cardiac death risk (SCD) stratification is of the highest importance in this cohort. This study aimed to investigate genotype–phenotype association regarding clinical outcome and disease progression in pediatric onset HCM. Medical charts from forty-nine patients with pediatric HCM who had undergone genetic testing were reviewed for retrospective analysis. Demographic, clinical, transthoracic echocardiographic, electrocardiographic, long-term electrocardiogram, cardiopulmonary exercise test, cardiac magnetic resonance, and medication data were recorded. Childhood onset HCM was diagnosed in 29 males and 20 females. Median age at last follow-up was 18.7 years (range 2.6–51.7 years) with a median follow-up time since diagnosis of 8.5 years (range 0.2–38.0 years). Comparison of patients carrying mutations in distinct genes and comparison of genotype-negative with genotype-positive individuals, revealed no differences in functional classification, LV morphology, hypertrophy, systolic and diastolic function, fibrosis and cardiac medication. Patients with compound mutations had a significantly higher risk for major arrhythmic events than a single-mutation carrier. No association between affected genes and disease severity or progression was identified in this cohort.Kathrin PollmannEmanuel KalteneckerJulia SchleihaufPeter EwertAgnes GörlachCordula M. WolfMDPI AGarticlepediatric onset hypertrophic cardiomyopathymajor arrhythmic eventssudden cardiac death risk stratificationgenotype–phenotype associationMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5256, p 5256 (2021)
institution DOAJ
collection DOAJ
language EN
topic pediatric onset hypertrophic cardiomyopathy
major arrhythmic events
sudden cardiac death risk stratification
genotype–phenotype association
Medicine
R
spellingShingle pediatric onset hypertrophic cardiomyopathy
major arrhythmic events
sudden cardiac death risk stratification
genotype–phenotype association
Medicine
R
Kathrin Pollmann
Emanuel Kaltenecker
Julia Schleihauf
Peter Ewert
Agnes Görlach
Cordula M. Wolf
Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
description Hypertrophic cardiomyopathy (HCM) is associated with adverse left ventricular (LV) remodeling causing dysfunction and malignant arrhythmias. Severely affected patients present with disease onset during childhood and sudden cardiac death risk (SCD) stratification is of the highest importance in this cohort. This study aimed to investigate genotype–phenotype association regarding clinical outcome and disease progression in pediatric onset HCM. Medical charts from forty-nine patients with pediatric HCM who had undergone genetic testing were reviewed for retrospective analysis. Demographic, clinical, transthoracic echocardiographic, electrocardiographic, long-term electrocardiogram, cardiopulmonary exercise test, cardiac magnetic resonance, and medication data were recorded. Childhood onset HCM was diagnosed in 29 males and 20 females. Median age at last follow-up was 18.7 years (range 2.6–51.7 years) with a median follow-up time since diagnosis of 8.5 years (range 0.2–38.0 years). Comparison of patients carrying mutations in distinct genes and comparison of genotype-negative with genotype-positive individuals, revealed no differences in functional classification, LV morphology, hypertrophy, systolic and diastolic function, fibrosis and cardiac medication. Patients with compound mutations had a significantly higher risk for major arrhythmic events than a single-mutation carrier. No association between affected genes and disease severity or progression was identified in this cohort.
format article
author Kathrin Pollmann
Emanuel Kaltenecker
Julia Schleihauf
Peter Ewert
Agnes Görlach
Cordula M. Wolf
author_facet Kathrin Pollmann
Emanuel Kaltenecker
Julia Schleihauf
Peter Ewert
Agnes Görlach
Cordula M. Wolf
author_sort Kathrin Pollmann
title Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
title_short Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
title_full Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
title_fullStr Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
title_full_unstemmed Compound Mutation in Cardiac Sarcomere Proteins Is Associated with Increased Risk for Major Arrhythmic Events in Pediatric Onset Hypertrophic Cardiomyopathy
title_sort compound mutation in cardiac sarcomere proteins is associated with increased risk for major arrhythmic events in pediatric onset hypertrophic cardiomyopathy
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/56fe6d338de242908ba8135881ab8790
work_keys_str_mv AT kathrinpollmann compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
AT emanuelkaltenecker compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
AT juliaschleihauf compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
AT peterewert compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
AT agnesgorlach compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
AT cordulamwolf compoundmutationincardiacsarcomereproteinsisassociatedwithincreasedriskformajorarrhythmiceventsinpediatriconsethypertrophiccardiomyopathy
_version_ 1718411743125831680